Page 1 of Clinical Trials for Revlimid, 454 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)
Last Updated: February 14, 2012
Condition(s): Relapsed or Refractory Multiple Myeloma; Kahler; Revlimid; Endoxan; Prednisone
2
Recruiting
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age
Last Updated: May 1, 2012
Condition(s): Acute Myeloid Leukemia; Acute Myelogenous Leukemia
3
Completed
Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
Last Updated: February 18, 2011
Condition(s): Cutaneous Lupus Erythematosus (CLE)
4
Recruiting
Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients
Last Updated: December 28, 2011
Condition(s): Multiple Myeloma
5
Active, not recruiting
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Last Updated: December 19, 2011
Condition(s): Follicular Lymphoma; Marginal Zone B-Cell Lymphoma; MALT Lymphoma; Lymphoma of Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Lymphocytic; Waldenstrom Macroglobulinemia; Mantle-Cell Lymphoma
6
Recruiting
Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
Last Updated: September 8, 2011
Condition(s): Relapsed Multiple Myeloma
7
Recruiting
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Last Updated: September 8, 2010
Condition(s): Chronic Lymphocytic Leukemia; CLL; Untreated; Front-line; First-Line; Initial Therapy
8
Not yet recruiting
Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy
Last Updated: December 28, 2011
Condition(s): Multiple Myeloma
9
Active, not recruiting
Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Last Updated: May 21, 2012
Condition(s): Myelodysplastic Syndrome
10
Recruiting
Use of Thalidomide, Lenalidomide, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
Last Updated: March 19, 2012
Condition(s): Multiple Myeloma
11
Recruiting
Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Last Updated: September 9, 2010
Condition(s): Chronic Lymphocytic Leukemia; CLL
12
Terminated
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Last Updated: April 10, 2006
Condition(s): Ovarian Cancer
13
Recruiting
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Last Updated: April 23, 2012
Condition(s): Multiple Myeloma; Plasma Cell Neoplasm
14
Terminated
Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)
Last Updated: August 24, 2011
Condition(s): Graft-versus-Host Disease
15
Active, not recruiting
Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer
Last Updated: August 23, 2011
Condition(s): Prostate Cancer
16
Terminated
Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL
Last Updated: December 10, 2010
Condition(s): Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia
17
Completed
Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
Last Updated: March 21, 2011
Condition(s): Chronic Lymphocytic Leukemia; Leukemia
18
Terminated
A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Last Updated: August 27, 2009
Condition(s): Diffuse Large B-cell Lymphoma
19
Completed
Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality
Last Updated: April 12, 2011
Condition(s): Myelodysplastic Syndromes
20
Active, not recruiting
A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older
Last Updated: May 10, 2012
Condition(s): Newly Diagnosed Multiple Myeloma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Revlimid

Page 1 of Clinical Trials for Revlimid, 454 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About